← FDA Drug Approvals (Drugs@FDA)

TEMOZOLOMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EXTROVIS · Approved 2016-06-29

Drug application

FDA Application #

ANDA205227

Application type

Abbreviated New Drug Application (Generic)

Brand name

TEMOZOLOMIDE

Generic name

Temozolomide

Active ingredients

TEMOZOLOMIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

EXTROVIS

First approval

2016-06-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown